Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' HEBBAR M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 55 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Launay, D; Hebbar, M; Hatron, PY; Michon-Pasturel, U; Queyrel, V; Hachulla, E; Devulder, B
      Relationship between parity and clinical and biological features in patients with systemic sclerosis

      JOURNAL OF RHEUMATOLOGY
    2. Launay, D; Hachulla, E; Hatron, PY; Goullard, L; Onimus, T; Robin, S; Fauchais, AL; Queyrel, V; Michon-Pasturel, U; Hebbar, M; Saulnier, F; Devulder, B
      Aerosolized iloprost in CREST syndrome related pulmonary hypertension

      JOURNAL OF RHEUMATOLOGY
    3. Launay, D; Hachulla, E; Hatron, PY; Michon-Pasturel, U; Hebbar, M; Queyrel, V; Goullard, L; Robin, S; Remy-Jardin, M; Devulder, B
      Pulmonary hypertension screening in systemic sclerosis: apropos 67 patients.

      REVUE DE MEDECINE INTERNE
    4. Fauchais, AL; Michon-Pasturel, U; Rugale, C; Asseray, N; Bulckaen, H; Queyrel, V; Puisieux, F; Hebbar, M; Hachulla, E; Hatron, PY; Devulder, B
      Wegener's granulomatosis in the elderly subject

      REVUE DE MEDECINE INTERNE
    5. Descamps, S; Pawlowski, V; Revillion, F; Hornez, L; Hebbar, M; Boilly, B; Hondermarck, H; Peyrat, JP
      Expression of nerve growth factor receptors and their prognostic value in human breast cancer

      CANCER RESEARCH
    6. Pawlowski, V; Revillion, F; Hebbar, M; Hornez, L; Peyrat, JP
      Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay

      CLINICAL CANCER RESEARCH
    7. Hebbar, M; Peyrat, JP
      Significance of soluble endothelial molecule E-selectin in patients with breast cancer

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    8. Blanckaert, VD; Hornez, L; Hebbar, M; Louchez, MM; Hondermarck, H; Peyrat, JP
      Distribution and prognostic value of the fibroblast growth factor-2 low-affinity binding sites in human breast cancer

      ANTICANCER RESEARCH
    9. Lambert, M; Hebbar, M; Viget, N; Hatron, PY; Hachulla, E; Devulder, B
      Bronchiolitis obliterans with organized pneumonia, a rare complication of primary Sjogren's syndrome.

      REVUE DE MEDECINE INTERNE
    10. Queyrel, V; Michon-Pasturel, U; Leroy, X; Fauchais, AL; Kindt, V; Hebbar, M; Hachulla, E; Hatron, PY; Devulder, B; Remy, J
      Intravascular epithelioid hemangioendothelioma

      REVUE DE MEDECINE INTERNE
    11. Hebbar, M; Peyrat, JP; Hornez, L; Hatron, PY; Hachulla, E; Devulder, B
      Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis

      ARTHRITIS AND RHEUMATISM
    12. Hebbar, M; Revillion, F; Louchez, MM; Fournier, C; Bonneterre, J; Peyrat, JP
      Prognostic value of circulating soluble E-selectin concentrations in node-negative breast cancer patients

      CLINICAL CANCER RESEARCH
    13. Kyndt, X; Launay, D; Hebbar, M; Hatron, PY; Fournier, C; Michon-Pasturel, U; Hachulla, E; Devulder, B
      Influence of age on the clinical and biological features of systemic sclerosis

      REVUE DE MEDECINE INTERNE
    14. HEBBAR M; REVILLION F; LOUCHEZ MM; VILAIN MO; FOURNIER C; BONNETERRE J; PEYRAT JP
      THE RELATIONSHIP BETWEEN CONCENTRATIONS OF CIRCULATING SOLUBLE E-SELECTIN AND CLINICAL, PATHOLOGICAL, AND BIOLOGICAL FEATURES IN PATIENTS WITH BREAST-CANCER

      Clinical cancer research
    15. HEBBAR M; REVILLION F; LOUCHEZ MM; VILAIN MO; FOURNIER C; BONNETERRE J; PEYRAT JP
      THE RELATIONSHIP BETWEEN CONCENTRATIONS OF CIRCULATING SOLUBLE E-SELECTIN AND CLINICAL, PATHOLOGICAL, AND BIOLOGICAL FEATURES IN PATIENTS WITH BREAST-CANCER

      Clinical cancer research
    16. Blanckaert, VD; Hebbar, M; Louchez, MM; Vilain, MO; Schelling, ME; Peyrat, JP
      Basic fibroblast growth factor receptors and their prognostic value in human breast cancer

      CLINICAL CANCER RESEARCH
    17. VANLEMMENS L; HEBBAR M; PEYRAT JP; BONNETERRE J
      AGE AS A PROGNOSTIC FACTOR IN BREAST-CANCER

      Anticancer research
    18. HEBBAR M; JANIN A; LASSALLE P; HATRON PY; HACHULLA E; TONNEL AB; DEVULDER B
      CORRELATIONS BETWEEN ENDOTHELIAL E-SELECTIN EXPRESSION IN SALIVARY-GLANDS AND CLINICAL OR BIOLOGICAL FEATURES IN PATIENTS WITH SYSTEMIC-SCLEROSIS

      La Revue de medecine interne
    19. LAUNAY D; HEBBAR M; JANIN A; HACHULLA E; HATRON PY; DEVULDER B
      PRIMARY BILIARY-CIRRHOSIS AND SYSTEMIC-SCLEROSIS (REYNOLDS-SYNDROME) - 8 NEW CASES - INTEREST OF THE LABIAL SALIVARY-GLAND BIOPSY

      La Revue de medecine interne (Paris)
    20. RECCHI MA; HEBBAR M; HORNEZ L; HARDUINLEPERS A; PEYRAT JP; DELANNOY P
      MULTIPLEX REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION ASSESSMENT OF SIALYLTRANSFERASE EXPRESSION IN HUMAN BREAST-CANCER

      Cancer research
    21. PREUDHOMME C; NISSE C; HEBBAR M; VANRUMBEKE M; BRIZARD A; LAI JL; FENAUX P
      GLUTATHIONE-S-TRANSFERASE THETA-1 GENE DEFECTS IN MYELODYSPLASTIC SYNDROMES AND THEIR CORRELATION WITH KARYOTYPE AND EXPOSURE TO POTENTIAL CARCINOGENS

      Leukemia
    22. HEBBAR M; KOZLOWSKI D; WATTEL E; MASTRINI S; DIEVART M; DUCLOS B; BONAZ B; DALMAGNE H; BELAICHE J; COLOMBEL JF; FENAUX P
      ASSOCIATION BETWEEN MYELODYSPLASTIC SYNDROMES AND INFLAMMATORY BOWEL DISEASES - REPORT OF 7 NEW CASES AND REVIEW OF THE LITERATURE

      Leukemia
    23. WATTEL E; DEBOTTON S; HEBBAR M; MERLAT A; BAUTERS F; FENAUX P
      INTENSIVE CHEMOTHERAPY IN DE-NOVO MDS - OUTCOME OF PATIENTS WHO ACHIEVED PARTIAL REMISSION (PR)

      Experimental hematology
    24. KYNDT X; HEBBAR M; QUEYREL V; HACHULLA E; HATRON PY; DEVULDER B
      SYSTEMIC-SCLEROSIS AND MALIGNANCY - ASSES SMENT OF RISK-FACTORS ASSOCIATED WITH THE DEVELOPMENT OF CANCER IN 123 PATIENTS WITH SYSTEMIC-SCLEROSIS

      La Revue de medecine interne
    25. LAMBERT M; HEBBAR M; HACHULLA E; HUGLO D; GAMBIER L; HATRON PY; DEVULDER B
      GALLIUM SCINTIGRAPHY REVEALING A SMALL-IN TESTINAL TUMOR

      La Revue de medecine interne
    26. LAUNAY D; HEBBAR M; LOUYOT J; HACHULLA E; HATRON PY; DEVULDER B
      ASSOCIATION BETWEEN YELLOW NAIL SYNDROME AND RHEUMATOID-ARTHRITIS - REGRESSION WITH CHRYSOTHERAPY

      La Revue de medecine interne
    27. HEBBAR M; DEMOULINS H; VIGET N; DEVULDER B; QUANDALLE P
      METASTATIC PLACENTAL CHORIOCARCINOMA

      La Revue de medecine interne
    28. HEBBAR M
      PLACE OF FIRST-LINE PALLIATIVE CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL-CANCER

      La Revue de medecine interne
    29. LAMBERT M; HEBBAR M; HACHULLA E; HATRON PY; DEVULDER B
      SJOGRENS-SYNDROME WITH CRYOGLOBULINEMIA

      La Revue de medecine interne
    30. KOZLOWSKI D; HEBBAR M; WATTEL E; BELAICHE J; BONAZ B; COLOMBEL JF; FENAUX P
      CONCURRENCE OF INFLAMMATORY BOWEL-DISEASE AND MYELODYSPLASTIC SYNDROMES

      Gut
    31. NISSE C; GRANDBASTIEN B; BRIZARD A; HEBBAR M; HAGUENOER JM; FENAUX P
      MYELODYSPLASTIC SYNDROMES (MDS) AND EXPOSURE TO OCCUPATIONAL OR ENVIRONMENTAL HAZARDS - A CASE-CONTROL STUDY

      Blood
    32. HEBBAR M; LASSALLE P; DELNESTE Y; HATRON PY; DEVULDER B; TONNEL AB; JANIN A
      ASSESSMENT OF ANTIENDOTHELIAL CELL ANTIBODIES IN SYSTEMIC-SCLEROSIS AND SJOGRENS-SYNDROME

      Annals of the Rheumatic Diseases
    33. REVILLION F; HEBBAR M; BONNETERRE J; PEYRAT JP
      PLASMA C-ERBB2 CONCENTRATIONS IN RELATION TO CHEMOTHERAPY IN BREAST-CANCER PATIENTS

      European journal of cancer
    34. HEBBAR M
      3RD FRENCH-ARABIC CONGRESS IN INTERNAL-ME DICINE, CASABLANCA, 20 APRIL 1996

      La Revue de medecine interne
    35. MARGUERIE L; HEBBAR M; LORTHIOIR M; HACHULLA E; HATRON PY; TOURNOYS MH; DEVULDER B
      MENINGORADICULITIS AND SYSTEMATIC LUPUS-E RYTHEMATOSUS - PARTICIPATION OF ANTIPHOSPHOLIPID ANTIBODIES

      La Revue de medecine interne
    36. HEBBAR M; KAPLAN C; CAULIER MT; WATTEL E; MOREL P; WETTERWALD M; BAUTERS F; FENAUX P
      LOW INCIDENCE OF SPECIFIC ANTIPLATETLET ANTIBODIES DETECTED BY THE MAIPA ASSAY IN THE SERUM OF THROMBOCYTOPENIC MDS PATIENTS AND LACK OF CORRELATION BETWEEN PLATELET AUTOANTIBODIES, PLATELET LIFE-SPAN AND RESPONSE TO DANAZOL THERAPY

      British Journal of Haematology
    37. MOREL P; DECLERCQ C; HEBBAR M; BAUTERS F; FENAUX P
      PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES - CRITICAL ANALYSIS OF THE IMPACT OF AGE AND GENDER AND FAILURE TO IDENTIFY A VERY-LOW-RISKGROUP USING STANDARD MORTALITY RATIO TECHNIQUES

      British Journal of Haematology
    38. PREUDHOMME C; NISSE C; HEBBAR M; VANRUMBEKE M; BRIZARD A; LAI JL; FENAUX P
      GLUTATHIONE-S-TRANSFERASE THETA-1 (GSTT1) GENE S-TRANSFERASE DEFECTS IN MYELODYSPLASTIC SYNDROMES (MDS) AND THEIR CORRELATION WITH KARYOTYPE AND EXPOSURE TO POTENTIAL CARCINOGENS

      Blood
    39. HEBBAR M; GILLET JM; HACHULLA E; LASSALLE P; HATRON PY; DEVULDER B; JANIA A
      EXPRESSION OF E-SELECTIN, TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) ANDMAST-CELL INFILTRATION IN THE SALIVARY-GLANDS OF PATIENTS WITH RAYNAUDS-PHENOMENON BEFORE PROGRESSION TO SYSTEMIC-SCLEROSIS

      Arthritis and rheumatism
    40. HEBBAR M; GILLOT JM; HACHULLA E; LASSALLE P; HATRON PY; DEVULDER B; JANIN A
      EARLY EXPRESSION OF E-SELECTIN, TUMOR-NECROSIS-FACTOR-ALPHA, AND MAST-CELL INFILTRATION IN THE SALIVARY-GLANDS OF PATIENTS WITH SYSTEMIC-SCLEROSIS

      Arthritis and rheumatism
    41. HEBBAR M; BROUILLARD M; WATTEL E; DECOULX M; HATRON PY; DEVULDER B; FENAUX P
      ASSOCIATION OF MYELODYSPLASTIC SYNDROME AND RELAPSING POLYCHONDRITIS - FURTHER EVIDENCE

      Leukemia
    42. HEBBAR M; VANLEMMENS L; LECOMTE S; BONNETERRE J
      IMMUNOTHERAPY IN MALIGNANT-MELANOMA - NEW PERSPECTIVES

      La Revue de medecine interne
    43. HEBBAR M; HEBBARSAVEAN K; FENAUX P
      SYSTEMIC-DISEASES IN MYELODYSPLASTIC SYND ROMES

      La Revue de medecine interne
    44. HEBBAR M; HECQUET B; VANLEMMENS L; LECOMTE S; PION JM; ADENIS A; BONNETERRE J
      INSUFFICIENT EFFICACY OF THE USE OF ONE 8 -MG TABLET ONDANSETRON IN THE PREVENTION OF FEC CHEMOTHERAPY-INDUCED EMESIS

      Bulletin du cancer
    45. HEBBAR M; KAPLAN C; CAULIER MT; WATTEL E; MOREL P; WETTERWALD M; BAUTERS F; FENAUX P
      PROSPECTIVE ASSESSMENT OF THE MECHANISM OF THROMBOCYTOPENIA AND ITS TREATMENT BY DANAZOL IN MYELODYSPLASTIC SYNDROMES (MDS) - A REPORT ON 28 CASES

      Blood
    46. HEBBAR M; LASSALLE P; JANIN A; VANHEE D; BISIAU S; HATRON PY; TONNEL AB; GOSSELIN B
      E-SELECTIN EXPRESSION IN SALIVARY ENDOTHELIAL-CELLS AND SERA FROM PATIENTS WITH SYSTEMIC-SCLEROSIS - ROLE OF RESIDENT MAST CELL-DERIVED TUMOR-NECROSIS-FACTOR-ALPHA

      Arthritis and rheumatism
    47. HEBBAR M; HEBBARSAVEAN K; HACHULLA E; BROUILLARD M; HATRON PY; DEVULDER B
      PARTICIPATION OF CRYOGLOBULINEMIA IN THE SEVERE PERIPHERAL NEUROPATHIES OF PRIMARY SJOGRENS-SYNDROME

      Annales de medecine interne
    48. HEBBAR M; GOSSET D; HATRON PY; DEVULDER B
      PANCREATIC TUBERCULOSIS IN A PATIENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

      La Presse medicale
    49. HEBBAR M; GOSSET D; HATRON PY; DEVULDER B
      ACUTE-PANCREATITIS, SYSTEMIC LUPUS-ERYTHE MATOSUS AND ANTIPHOSPHOLIPID ANTIBODY SYNDROME

      La Revue de medecine interne
    50. HEBBAR M; JANIN A; HUGLO D; COPIN MC; LAFYATIS R; DEVULDER B; MARCHANDISE X; GOSSET D
      XEROSTOMIA IN SYSTEMIC-SCLEROSIS - SYSTEMATIC EVALUATION BY SALIVARY SCINTIGRAPHY AND LIP BIOPSY IN 34 PATIENTS

      Arthritis and rheumatism
    51. MOREL P; HEBBAR M; LAI JL; DUHAMEL A; PREUDHOMME C; WATTEL E; BAUTERS F; FENAUX P
      CYTOGENETIC ANALYSIS HAS STRONG INDEPENDENT PROGNOSTIC VALUE IN DE-NOVO MYELODYSPLASTIC SYNDROMES AND CAN BE INCORPORATED IN A NEW SCORING SYSTEM - A REPORT ON 408 CASES

      Leukemia
    52. HEBBAR M; GOSSET D; DUPRIEZ B; HATRON PY; BAUTERS F; DEVULDER B
      DERMATOPOLYMYOSITIS AND CHRONIC LYMPHOCYT IC-LEUKEMIA - REPORT OF 2 CASES

      La Revue de medecine interne
    53. WATTEL E; HECQUET B; GRAHEK D; HEBBAR M; MOREL P; LAI JL; BAUTERS F; FENAUX P
      LONG-TERM SURVIVORS IN MYELODYSPLASTIC SYNDROMES - A REPORT ON 63 CASES AND COMPARISON WITH SHORT AND INTERMEDIATE SURVIVORS

      Leukemia research
    54. WATTEL E; LAI JL; HEBBAR M; PREUDHOMME C; GRAHEK D; MOREL P; BAUTERS F; FENAUX P
      DE-NOVO MYELODYSPLASTIC SYNDROME (MDS) WITH DELETION OF THE LONG ARM OF CHROMOSOME-20 - A SUBTYPE OF MDS WITH DISTINCT HEMATOLOGICAL AND PROGNOSTIC FEATURES

      Leukemia research
    55. MOREL P; HEBBAR M; LAI JL; PREUDHOMME C; WATTEL E; BAUTERS F; FENAUX P
      KARYOTYPE (KA) HAS STRONG INDEPENDENT PROGNOSTIC VALUE IN DENOVO MYELODYSPLASTIC SYNDROMES (MDS) AND CAN BE INCLUDED IN NEW SCORING SYSTEMS- A REPORT ON 408 CASES

      British Journal of Haematology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 15:24:54